Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Stock Short Interest Declines 69.9%

Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 4,009 shares, a decline of 69.9% from the September 30th total of 13,327 shares. Based on an average daily trading volume, of 12,691 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the shares of the stock are sold short.

Roundhill GLP-1 & Weight Loss ETF Price Performance

NASDAQ:OZEM opened at $29.50 on Wednesday. The stock has a market capitalization of $55.16 million, a PE ratio of 22.34 and a beta of 0.47. Roundhill GLP-1 & Weight Loss ETF has a fifty-two week low of $27.64 and a fifty-two week high of $37.15. The business’s 50-day simple moving average is $31.32 and its 200-day simple moving average is $32.27.

Institutional Investors Weigh In On Roundhill GLP-1 & Weight Loss ETF

An institutional investor recently raised its position in Roundhill GLP-1 & Weight Loss ETF stock. Envestnet Asset Management Inc. lifted its position in shares of Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) by 27.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,418 shares of the company’s stock after buying an additional 5,016 shares during the quarter. Envestnet Asset Management Inc. owned about 1.25% of Roundhill GLP-1 & Weight Loss ETF worth $762,000 at the end of the most recent reporting period.

Roundhill GLP-1 & Weight Loss ETF Company Profile

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.